Skip to main content
Top
Published in: International Urogynecology Journal 1/2022

01-01-2022 | Stress Incontinence | Original Article

Microablative radiofrequency versus pelvic floor muscle training for stress urinary incontinence: a randomized controlled trial

Authors: Helena Slongo, Ana Lygia B. Lunardi, Cássio L. Z. Riccetto, Helymar C. Machado, Cássia R. T. Juliato

Published in: International Urogynecology Journal | Issue 1/2022

Login to get access

Abstract

Introduction and hypothesis

The efficacy of radiofrequency (RF) in stress urinary incontinence (SUI) is as yet unknown. The aim was to compare the effect of fractional microablative RF and pelvic floor muscle training (PFMT) against the combination of both therapies (RF + PFMT) in the SUI and on genitourinary syndrome (GSM).

Methods

This was a three-arm randomized clinical trial including 117 climacteric women with SUI. In group 1 the treatment consisted of three monthly sessions of RF; in group 2 it was 12 weekly PFMT sessions; in group 3 it was RF + PFMT simultaneously. Assessments at baseline and 30 days after the end of therapy were conducted using validated questionnaires and scales for urinary, vaginal, and sexual functions and cytology for vaginal trophy.

Results

Urinary scores improved significantly in all three groups post-treatment (p < 0.001) with a higher improvement in the RF + PFMT group (p = 0.002). One-hour pad test results were equal in the three groups. Vaginal symptoms showed an incremental improvement in RF (p < 0.007), and vaginal laxity showed a similar improvement in the three groups (p = 0.323). Vaginal Health Index score was more significant in RF and RF + PFMT groups. Sexual function improved in RF and PFMT.

Conclusions

The association between RF and PFMT showed significant improvement in the SUI symptoms assessed by questionnaire. The vaginal symptoms and dryness showed greater improvement in the RF treatment and vaginal laxity showed similar improvement in the three groups. The combination of RF and PFMT in sexual function did not show benefits superior to those achieved by the therapies alone.
Literature
1.
go back to reference Parish SJ, Nappi RE, Krychman ML, Kellogg-Spadt S, Simon JA, Goldstein JA, et al. Impact of vulvovaginal health on postmenopausal women: a review of surveys on symptoms of vulvovaginal atrophy. Int J Womens Health. 2013;5:437–47.CrossRef Parish SJ, Nappi RE, Krychman ML, Kellogg-Spadt S, Simon JA, Goldstein JA, et al. Impact of vulvovaginal health on postmenopausal women: a review of surveys on symptoms of vulvovaginal atrophy. Int J Womens Health. 2013;5:437–47.CrossRef
2.
go back to reference Dumoulin C, Cacciari LP, Hay-Smith EJC. Pelvic floor muscle training versus no treatment, or inactive control treatments, for urinary incontinence in women. Cochrane Database Syst Rev. 2018;10(10):CD005654.PubMed Dumoulin C, Cacciari LP, Hay-Smith EJC. Pelvic floor muscle training versus no treatment, or inactive control treatments, for urinary incontinence in women. Cochrane Database Syst Rev. 2018;10(10):CD005654.PubMed
3.
go back to reference Pereira VS, de Melo MV, Correia GN, Driusso P. Long-term effects of pelvic floor muscle training with vaginal cone in post-menopausal women with urinary incontinence: a randomized controlled trial. Neurourol Urodyn. 2013;32(1):48–52.CrossRef Pereira VS, de Melo MV, Correia GN, Driusso P. Long-term effects of pelvic floor muscle training with vaginal cone in post-menopausal women with urinary incontinence: a randomized controlled trial. Neurourol Urodyn. 2013;32(1):48–52.CrossRef
4.
go back to reference Malallah MA, Al-Shaiji TF. Pharmacological treatment of pure stress urinary incontinence: a narrative review. Int Urogynecol J. 2015;26(4):477–85.CrossRef Malallah MA, Al-Shaiji TF. Pharmacological treatment of pure stress urinary incontinence: a narrative review. Int Urogynecol J. 2015;26(4):477–85.CrossRef
6.
go back to reference Tadir Y, Gaspar A, Lev-Sagie A, Alexiades M, Alinsod R, Bader A, et al. Light and energy based therapeutics for genitourinary syndrome of menopause: Consensus and controversies. Lasers Surg Med. 2017;49(2):137–59.CrossRef Tadir Y, Gaspar A, Lev-Sagie A, Alexiades M, Alinsod R, Bader A, et al. Light and energy based therapeutics for genitourinary syndrome of menopause: Consensus and controversies. Lasers Surg Med. 2017;49(2):137–59.CrossRef
7.
go back to reference Vicariotto F, Raichi M. Technological evolution in the radiofrequency treatment of vaginal laxity and menopausal vulvo-vaginal atrophy and other genitourinary symptoms: first experiences with a novel dynamic quadripolar device. Minerva Ginecol. 2016;68(3):225–36.PubMed Vicariotto F, Raichi M. Technological evolution in the radiofrequency treatment of vaginal laxity and menopausal vulvo-vaginal atrophy and other genitourinary symptoms: first experiences with a novel dynamic quadripolar device. Minerva Ginecol. 2016;68(3):225–36.PubMed
8.
go back to reference Kamilos MF, Borrelli CL. New therapeutic option in genitourinary syndrome of menopause: pilot study using microablative fractional radiofrequency. Einstein (Sao Paulo). 2017;15(4):445–51.CrossRef Kamilos MF, Borrelli CL. New therapeutic option in genitourinary syndrome of menopause: pilot study using microablative fractional radiofrequency. Einstein (Sao Paulo). 2017;15(4):445–51.CrossRef
9.
go back to reference Lordelo P, Vilas Boas A, Sodre D, Lemos A, Tozetto S, Brasil C. New concept for treating female stress urinary incontinence with radiofrequency. Int Braz J Urol. 2017;43(5):896–902.CrossRef Lordelo P, Vilas Boas A, Sodre D, Lemos A, Tozetto S, Brasil C. New concept for treating female stress urinary incontinence with radiofrequency. Int Braz J Urol. 2017;43(5):896–902.CrossRef
10.
go back to reference Caruth JC. Evaluation of the safety and efficacy of a novel radiofrequency device for vaginal treatment. Surg Technol Int. 2018;32:145–9.PubMed Caruth JC. Evaluation of the safety and efficacy of a novel radiofrequency device for vaginal treatment. Surg Technol Int. 2018;32:145–9.PubMed
11.
go back to reference Shobeiri SA, Kerkhof MH, Minassian VA, Bazi T. IUGA committee opinion: laser-based vaginal devices for treatment of stress urinary incontinence, genitourinary syndrome of menopause, and vaginal laxity. Int Urogynecol J. 2019;30(3):371–6.CrossRef Shobeiri SA, Kerkhof MH, Minassian VA, Bazi T. IUGA committee opinion: laser-based vaginal devices for treatment of stress urinary incontinence, genitourinary syndrome of menopause, and vaginal laxity. Int Urogynecol J. 2019;30(3):371–6.CrossRef
12.
go back to reference Abrams P, Andersson KE, Apostolidis A, Birder L, Bliss D, Brubaker L, et al. 6th International Consultation on Incontinence. Recommendations of the International Scientific Committee: evaluation and treatment of urinary incontinence, pelvic organ prolapse and fecal incontinence. Neurourol Urodyn. 2018;37(7):2271–2.CrossRef Abrams P, Andersson KE, Apostolidis A, Birder L, Bliss D, Brubaker L, et al. 6th International Consultation on Incontinence. Recommendations of the International Scientific Committee: evaluation and treatment of urinary incontinence, pelvic organ prolapse and fecal incontinence. Neurourol Urodyn. 2018;37(7):2271–2.CrossRef
13.
go back to reference Bump RC, Mattiasson A, Bø K, Brubaker LP, DeLancey JO, Klarskov P, et al. The standardization of terminology of female pelvic organ prolapse and pelvic floor dysfunction. Am J Obstet Gynecol. 1996;175(1):10–7.CrossRef Bump RC, Mattiasson A, Bø K, Brubaker LP, DeLancey JO, Klarskov P, et al. The standardization of terminology of female pelvic organ prolapse and pelvic floor dysfunction. Am J Obstet Gynecol. 1996;175(1):10–7.CrossRef
14.
go back to reference Tamanini JT, Dambros M, D’Ancona CA, Palma PC, Rodrigues Netto N. Validation of the International Consultation on Incontinence Questionnaire - Short Form (ICIQ-SF) for Portuguese. Rev Saude Publica. 2004;38(3):438–44.CrossRef Tamanini JT, Dambros M, D’Ancona CA, Palma PC, Rodrigues Netto N. Validation of the International Consultation on Incontinence Questionnaire - Short Form (ICIQ-SF) for Portuguese. Rev Saude Publica. 2004;38(3):438–44.CrossRef
15.
go back to reference Tamanini JT, Almeida FG, Girotti ME, Riccetto CL, Palma PC, Rios LA. The Portuguese validation of the International Consultation on Incontinence Questionnaire-Vaginal Symptoms (ICIQ-VS) for Brazilian women with pelvic organ prolapse. Int Urogynecol J Pelvic Floor Dysfunct. 2008;19(10):1385–91.CrossRef Tamanini JT, Almeida FG, Girotti ME, Riccetto CL, Palma PC, Rios LA. The Portuguese validation of the International Consultation on Incontinence Questionnaire-Vaginal Symptoms (ICIQ-VS) for Brazilian women with pelvic organ prolapse. Int Urogynecol J Pelvic Floor Dysfunct. 2008;19(10):1385–91.CrossRef
16.
go back to reference Pacagnella Rde C, Martinez EZ, Vieira EM. Construct validity of a Portuguese version of the Female Sexual Function Index. Cad Saude Publica. 2009;25(11):2333–44.CrossRef Pacagnella Rde C, Martinez EZ, Vieira EM. Construct validity of a Portuguese version of the Female Sexual Function Index. Cad Saude Publica. 2009;25(11):2333–44.CrossRef
17.
go back to reference Marinoff S, Turner M. Vulvar vestibulitis syndrome. Dermatol Clin 1992;10(2):435–44.CrossRef Marinoff S, Turner M. Vulvar vestibulitis syndrome. Dermatol Clin 1992;10(2):435–44.CrossRef
18.
go back to reference Driusso P, Beleza ACS. Avaliação fisioterapêutica da musculatura do assoalho pélvico feminino. São Paulo: Editora Manole; 2018. Driusso P, Beleza ACS. Avaliação fisioterapêutica da musculatura do assoalho pélvico feminino. São Paulo: Editora Manole; 2018.
19.
go back to reference Bachmann G. Urogenital aging: an old problem newly recognized. Maturitas. 1995;22(Suppl):S1–5.CrossRef Bachmann G. Urogenital aging: an old problem newly recognized. Maturitas. 1995;22(Suppl):S1–5.CrossRef
20.
go back to reference Meiseils A. The maturation value. Acta Cytol. 1967;11(4):249. Meiseils A. The maturation value. Acta Cytol. 1967;11(4):249.
21.
go back to reference Lalji S, Lozanova P. Evaluation of the safety and efficacy of a monopolar nonablative radiofrequency device for the improvement of vulvo-vaginal laxity and urinary incontinence. J Cosmet Dermatol. 2017;16(2):230–4.CrossRef Lalji S, Lozanova P. Evaluation of the safety and efficacy of a monopolar nonablative radiofrequency device for the improvement of vulvo-vaginal laxity and urinary incontinence. J Cosmet Dermatol. 2017;16(2):230–4.CrossRef
22.
go back to reference Leibaschoff G, Izasa PG, Cardona JL, Miklos JR, Moore R. Transcutaneous temperature controlled radiofrequency (TTCRF) for the treatment of menopausal vaginal/genitourinary symptoms. Surg Technol Int. 2016;29:149–59.PubMed Leibaschoff G, Izasa PG, Cardona JL, Miklos JR, Moore R. Transcutaneous temperature controlled radiofrequency (TTCRF) for the treatment of menopausal vaginal/genitourinary symptoms. Surg Technol Int. 2016;29:149–59.PubMed
23.
go back to reference Allan B, Bell S, Husarek K. Early feasibility study to evaluate the Viveve system for female stress urinary incontinence: interim 6-month report. J Womens Health. 2020;29(3):383–9.CrossRef Allan B, Bell S, Husarek K. Early feasibility study to evaluate the Viveve system for female stress urinary incontinence: interim 6-month report. J Womens Health. 2020;29(3):383–9.CrossRef
24.
go back to reference Millheiser LS, Pauls RN, Herbst SJ, Chen BH. Radiofrequency treatment of vaginal laxity after vaginal delivery: nonsurgical vaginal tightening. J Sex Med. 2010;7(9):3088–95.CrossRef Millheiser LS, Pauls RN, Herbst SJ, Chen BH. Radiofrequency treatment of vaginal laxity after vaginal delivery: nonsurgical vaginal tightening. J Sex Med. 2010;7(9):3088–95.CrossRef
25.
go back to reference Nappi R, Palacios S, Panay N, Particco M, Krychman M. Vulvar and vaginal atrophy in four European countries: evidence from the European REVIVE Survey. Climacteric. 2016;19(2):188–97.CrossRef Nappi R, Palacios S, Panay N, Particco M, Krychman M. Vulvar and vaginal atrophy in four European countries: evidence from the European REVIVE Survey. Climacteric. 2016;19(2):188–97.CrossRef
26.
go back to reference Salvatore S, Nappi R, Zerbinati N, Calligaro A, Ferrero S, Origoni M, et al. A 12-week treatment with fractional CO2 laser for vulvovaginal atrophy: a pilot study. Climacteric. 2014;17(4):363–9.CrossRef Salvatore S, Nappi R, Zerbinati N, Calligaro A, Ferrero S, Origoni M, et al. A 12-week treatment with fractional CO2 laser for vulvovaginal atrophy: a pilot study. Climacteric. 2014;17(4):363–9.CrossRef
Metadata
Title
Microablative radiofrequency versus pelvic floor muscle training for stress urinary incontinence: a randomized controlled trial
Authors
Helena Slongo
Ana Lygia B. Lunardi
Cássio L. Z. Riccetto
Helymar C. Machado
Cássia R. T. Juliato
Publication date
01-01-2022
Publisher
Springer International Publishing
Published in
International Urogynecology Journal / Issue 1/2022
Print ISSN: 0937-3462
Electronic ISSN: 1433-3023
DOI
https://doi.org/10.1007/s00192-021-04758-2

Other articles of this Issue 1/2022

International Urogynecology Journal 1/2022 Go to the issue